New at CADTH — April 2019


Project Line:
New at CADTH

News and Events

CADTH is pleased to announce the recipients of the 2019 CADTH Recognition Awards. Learn more here about this year’s recipients who have helped develop, support, and expand the use of health technology assessment in Canada.

CADTH is seeking nominations to its advisory and expert committees. We’re looking for six individuals with significant expertise in the Canadian health care system to join various committees. More information about the roles, the nomination process, honorarium, and time commitments is available here.

It is your last chance to register for the 2019 CADTH Symposium being held in Edmonton from April 14 to 16, 2019. Join us as international, national, provincial, and local experts share their insights on how health technology assessment is itself being transformed to support health system transformation.

Drug Reimbursement Recommendations

CADTH recently issued the following CADTH Canadian Drug Expert Committee (CDEC) drug reimbursement recommendations:

CADTH recently issued the following CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) Drug Reimbursement Recommendations:

  • brentuximab vedotin (Adcetris) for the treatment of patients with Hodgkin Lymphoma after failure of at least two multi-agent chemotherapy regimens in patients who are not autologous stem cell transplant candidates
  • nivolumab (Opdivo) for the adjuvant treatment of adult patients after complete resection of melanoma with regional lymph node involvement in transit metastases/satellites without metastatic nodes or distant metastases
  • cabozantinib (Cabometyx) for the treatment of patients with advanced renal cell carcinoma who have received prior therapy.

Optimal Use Recommendations

CADTH recently issued the following Optimal Use recommendations:

CADTH Reports

CADTH recently completed the following reports:

Rapid Response Reports — Drug

Rapid Response Reports — Medical Devices and Systems

Horizon Scans

Environmental Scans

Other Tools

Tell Us What You Think

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts: Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.